Submitted by Anonymous (not verified) on 14 October 2026 - 14:50
Human medicines European public assessment report (EPAR): Poherdy, pertuzumab, Date of authorisation: 23/04/2026, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Poherdy, pertuzumab, Date of authorisation: 23/04/2026, Revision: 2, Status: Authorised